Bellicum Pharmaceuticals Stock Filter Stocks by Fundamentals
BLCMDelisted Stock | USD 0.37 0.05 11.90% |
Bellicum Pharmaceuticals fundamentals help investors to digest information that contributes to Bellicum Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Bellicum Pink Sheet. The fundamental analysis module provides a way to measure Bellicum Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellicum Pharmaceuticals pink sheet.
Bellicum |
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
All Next | Launch Module |
Bellicum Fundamentals
Return On Equity | -1.06 | |||
Return On Asset | -0.61 | |||
Operating Margin | (19.69) % | |||
Current Valuation | (38.62 M) | |||
Shares Outstanding | 9.5 M | |||
Shares Owned By Insiders | 4.19 % | |||
Shares Owned By Institutions | 29.30 % | |||
Number Of Shares Shorted | 1.44 M | |||
Price To Earning | 8.50 X | |||
Price To Book | 1.00 X | |||
Price To Sales | 5.46 X | |||
Revenue | 1.5 M | |||
Gross Profit | (17.38 M) | |||
EBITDA | (28.93 M) | |||
Net Income | (24.97 M) | |||
Cash And Equivalents | 33.17 M | |||
Cash Per Share | 3.85 X | |||
Total Debt | 58 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 8.07 X | |||
Book Value Per Share | (1.11) X | |||
Cash Flow From Operations | (25.78 M) | |||
Short Ratio | 0.17 X | |||
Earnings Per Share | (1.57) X | |||
Target Price | 5.0 | |||
Number Of Employees | 13 | |||
Beta | 1.57 | |||
Market Capitalization | 3.52 M | |||
Total Asset | 23.82 M | |||
Retained Earnings | (575.42 M) | |||
Working Capital | 20.03 M | |||
Current Asset | 96.89 M | |||
Current Liabilities | 7.45 M | |||
Z Score | -0.31 | |||
Net Asset | 23.82 M |
About Bellicum Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellicum Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellicum Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellicum Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Bellicum Pink Sheet
If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |